Literature DB >> 1919014

The international standards for interleukin-1 alpha and interleukin-1 beta. Evaluation in an international collaborative study.

S Poole1, R E Gaines Das.   

Abstract

Three ampouled preparations of interleukin-1 alpha (IL-1 alpha) and three ampouled preparations of interleukin-1 beta (IL-1 beta) were evaluated by 13 laboratories in six countries for their suitability to serve as international standards for these materials. The preparation were assayed in in vitro and in vivo bioassays, radioreceptor assays and immunoassays. On the basis of the results reported here, with the agreement of participants in the study and with the authorization of the Expert Committee on Biological Standardization (ECBS) of the World Health Organization (WHO), one of the preparations of IL-1 alpha and one of the preparations of IL-1 beta were established as international standards for these materials. Further, since the relative activities of IL-1 alpha and IL-1 beta were dependent upon the assay systems used, it was decided that reference should be made to units of IL-1 alpha activity or IL-1 beta activity rather than to IL-1 activity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1919014     DOI: 10.1016/0022-1759(91)90286-o

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  6 in total

1.  Need for an external proficiency testing program for cytokines, chemokines, and plasma markers of immune activation.

Authors:  J L Fahey; N Aziz; J Spritzler; S Plaeger; P Nishanian; J L Lathey; J Seigel; A L Landay; R Kilarui; J L Schmitz; C White; D W Wara; R Akridge; J Cutili; S D Douglas; J Reuben; W T Shearer; M Nokta; R Polland; R Schooley; D Asthana; Y Mizrachi; M Waxdal
Journal:  Clin Diagn Lab Immunol       Date:  2000-07

2.  Levels of cytokines and immune activation markers in plasma in human immunodeficiency virus infection: quality control procedures.

Authors:  N Aziz; P Nishanian; J L Fahey
Journal:  Clin Diagn Lab Immunol       Date:  1998-11

3.  Variables that affect assays for plasma cytokines and soluble activation markers.

Authors:  N Aziz; P Nishanian; R Mitsuyasu; R Detels; J L Fahey
Journal:  Clin Diagn Lab Immunol       Date:  1999-01

4.  Biological and technical variables affecting immunoassay recovery of cytokines from human serum and simulated vaginal fluid: a multicenter study.

Authors:  Raina N Fichorova; Nicola Richardson-Harman; Massimo Alfano; Laurent Belec; Cedric Carbonneil; Silvia Chen; Lisa Cosentino; Kelly Curtis; Charlene S Dezzutti; Betty Donoval; Gustavo F Doncel; Melissa Donaghay; Jean-Charles Grivel; Esmeralda Guzman; Madeleine Hayes; Betsy Herold; Sharon Hillier; Carol Lackman-Smith; Alan Landay; Leonid Margolis; Kenneth H Mayer; Jenna-Malia Pasicznyk; Melanie Pallansch-Cokonis; Guido Poli; Patricia Reichelderfer; Paula Roberts; Irma Rodriguez; Hela Saidi; Rosaria Rita Sassi; Robin Shattock; James E Cummins
Journal:  Anal Chem       Date:  2008-05-17       Impact factor: 6.986

5.  In vivo mucosal delivery of bioactive human interleukin 1 receptor antagonist produced by Streptococcus gordonii.

Authors:  Susanna Ricci; Giovanni Macchia; Paolo Ruggiero; Tiziana Maggi; Paola Bossù; Li Xu; Donata Medaglini; Aldo Tagliabue; Lennart Hammarström; Gianni Pozzi; Diana Boraschi
Journal:  BMC Biotechnol       Date:  2003-09-17       Impact factor: 2.563

Review 6.  Cytokines as biomarkers in rheumatoid arthritis.

Authors:  Agata Burska; Marjorie Boissinot; Frederique Ponchel
Journal:  Mediators Inflamm       Date:  2014-03-09       Impact factor: 4.711

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.